Use of Fibrinolytics in Abdominal and Pleural Collections

Abstract

Fluid collections that are incompletely drained despite adequate catheter position, size, and number represent a minority of abscesses but a source of great frustration for patients, surgeons, and interventional radiologists. Drainage of such complex collections is known to be more effective with the adjunctive use of intracavitary fibrinolytic agents instilled via the drainage catheter. In this review article, we discuss the role of fibrinolytics specifically tissue plasminogen activator as explored by interventional radiologists in enhancing effective drainage of these complex abdominal and pelvic collections as well as complex pleural collections.

Keywords

abscess - empyema - percutaneous drainage - thrombolytic therapy - interventional radiology

• References

• 1 Beland MD, Gervais DA, Levis DA, Hahn PF, Arellano RS, Mueller PR. Complex abdominal and pelvic abscesses: efficacy of adjunctive tissue-type plasminogen activator for drainage. Radiology 2008; 247 (2) 567-573
• 2 Zuckerman DA, Reed MF, Howington JA, Moulton JS. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions. J Vasc Interv Radiol 2009; 20 (8) 1066-1069
• 3 Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest 1949; 28 (1) 173-190
• 4 Moulton JS, Moore PT, Mencini RA. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase. AJR Am J Roentgenol 1989; 153 (5) 941-945
• 5 Weinstein M, Restrepo R, Chait PG, Connolly B, Temple M, Macarthur C. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics 2004; 113 (3 Pt 1) e182-e185
• 6 Skeete DA, Rutherford EJ, Schlidt SA, Abrams JE, Parker LA, Rich PB. Intrapleural tissue plasminogen activator for complicated pleural effusions. J Trauma 2004; 57 (6) 1178-1183
• 7 Rahman NM, Maskell NA, West A , et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011; 365 (6) 518-526
• 8 Gervais DA, Levis DA, Hahn PF, Uppot RN, Arellano RS, Mueller PR. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage. Radiology 2008; 246 (3) 956-963
• 9 Sugimoto K, Kee ST, Semba CP, Razavi MK, Sze DY, Dake MD. Safety and efficacy of tissue plasminogen activator to treat loculated pleural effusions. J Vasc Interv Radiol 2001; 12 (Suppl) S107
• 10 Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology 2003; 228 (2) 370-378
• 11 Blom D, van Aalderen WM, Alders JM, Hoekstra MO. Life-threatening hemothorax in a child following intrapleural administration of urokinase [letter]. Pediatr Pulmonol 2000; 30 (6) 493
• 12 Lahorra JM, Haaga JR, Stellato T, Flanigan T, Graham R. Safety of intracavitary urokinase with percutaneous abscess drainage. AJR Am J Roentgenol 1993; 160 (1) 171-174
• 13 Diamond IR, Wales PW, Connolly B, Gerstle T. Tissue plasminogen activator for the treatment of intraabdominal abscesses in a neonate. J Pediatr Surg 2003; 38 (8) 1234-1236